Editor`s Picks

Stocks often surge in the months after mid-term elections Betting markets show high chance GOP snatches control of House and maybe even Senate Three investment themes that could catch tailwinds in...

Powell says Fed may slow pace of hikes but raise target Economists expect Fed to slow or halt quantitative tightening by mid-2023 Japan maintains low rates and supports yen as it hints at policy...

Technicals indicate a run toward $21 in first leg and $24 in second leg Weakness below $19.40 could trigger drop to $18.45 Silver an inflection point over potential to China’s COVID-Zero After...

Stocks finished the day higher on Monday, following on from Friday’s rally. Yields were higher across the board, and the dollar was again weaker. Still, the S&P was able to generate a 1ish%...

November has been the best month of the year for U.S. stocks counting since 1950 AII investor sentiment has improved—although it remains below the historical average However, 2022 keeps adding...

Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.The drugs account for 40% of the company's Q3 revenue when its COVID...

CPI reading due in China on Tuesday, in the US on Thursday China reiterates commitment to COVID-zero approach US CPI could give timeline on Fed rate pivot Weak number could signal recession From the...

It is a big week, with the CPI report on Thursday and a bunch of government bond auctions later this week. That means rates will be on the move, and word that the China zero covid policy will remain...